BioWorld Features Interview with Carisma on “First Cell Therapy to Employ Macrophages that Express a Chimeric Antigen Receptor”

April 29, 2019

Carisma leadership recently spoke with BioWorld about plans for a first clinical study using the novel therapeutic modality of chimeric antigen receptor expressing macrophages, “CAR-M”. A link to the article can be found here.